NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 52 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,000 | +50.0% | 40,800 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -55.6% | 40,800 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | 0.0% | 40,800 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | -40.0% | 40,800 | 0.0% | 0.00% | – |
| Q1 2018 | $15,000 | – | 40,800 | +3980.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -99.2% | 1,000 | -99.2% | 0.00% | – |
| Q1 2016 | $122,000 | +100.0% | 128,568 | +176.9% | 0.00% | – |
| Q4 2015 | $61,000 | +335.7% | 46,425 | +623.1% | 0.00% | – |
| Q3 2015 | $14,000 | +40.0% | 6,420 | +2.2% | 0.00% | – |
| Q2 2015 | $10,000 | -33.3% | 6,280 | -31.9% | 0.00% | – |
| Q1 2015 | $15,000 | -83.1% | 9,217 | -80.4% | 0.00% | – |
| Q4 2014 | $89,000 | +394.4% | 46,973 | +260.1% | 0.00% | – |
| Q3 2014 | $18,000 | -18.2% | 13,043 | -14.0% | 0.00% | – |
| Q2 2014 | $22,000 | -67.2% | 15,173 | -58.0% | 0.00% | – |
| Q1 2014 | $67,000 | -59.6% | 36,156 | -54.8% | 0.00% | – |
| Q4 2013 | $166,000 | +176.7% | 79,991 | +258.4% | 0.00% | – |
| Q3 2013 | $60,000 | -20.0% | 22,321 | -20.8% | 0.00% | – |
| Q2 2013 | $75,000 | – | 28,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|